Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lung Diseases × lorlatinib × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Recurrence 1 Neuroblastoma 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Glioma 1 Glioblastoma 1 Ganglioneuroblastoma 1 Diffuse Intrinsic Pontine Glioma 1 Astrocytoma 1 Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer 1 Advanced Non-Small Cell Lung Cancer 1

Interventions

Carboplatin 3 zipalertinib 2 pembrolizumab 2 durvalumab 2 Pemetrexed 2 Cisplatin 2 taletrectinib 1 sotorasib 1 selpercatinib 1 pralsetinib 1 ceralasertib 1 atezolizumab 1 alectinib 1 Tomography, Emission-Computed, Single-Photon 1 Radiosurgery 1 Paclitaxel 1 Omacor 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Docetaxel 1 Diarylheptanoids 1 4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡